1. Home
  2. MLYS vs SEAT Comparison

MLYS vs SEAT Comparison

Compare MLYS & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$26.85

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Vivid Seats Inc.

SEAT

Vivid Seats Inc.

HOLD

Current Price

$9.29

Market Cap

60.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
SEAT
Founded
2019
2001
Country
United States
United States
Employees
N/A
768
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
60.6M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MLYS
SEAT
Price
$26.85
$9.29
Analyst Decision
Strong Buy
Buy
Analyst Count
7
8
Target Price
$48.67
$18.06
AVG Volume (30 Days)
1.0M
117.9K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
37.43
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.59
$1.42
52 Week High
$47.65
$35.00

Technical Indicators

Market Signals
Indicator
MLYS
SEAT
Relative Strength Index (RSI) 43.95 67.87
Support Level $26.01 $5.72
Resistance Level $31.12 $18.41
Average True Range (ATR) 1.65 0.84
MACD -0.19 0.24
Stochastic Oscillator 30.96 95.86

Price Performance

Historical Comparison
MLYS
SEAT

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: